
    
      This study will use a consecutive patient sampling approach. All eligible participants
      admitted at each site will be approached. Caffeine and feedings will be administered per
      standard of care. Manipulations of caffeine dosing or feeding regimens will not be a part of
      this protocol. To minimize the amount of blood sampling, the investigators will use a sparse
      sampling methodology. Urine will be collected for analysis of caffeine and caffeine
      metabolite concentrations. Caffeine pharmacokinetics will be described by population
      pharmacokinetic analysis. Urinary concentrations of caffeine and its metabolites will be used
      to calculate metabolic ratios as markers of enzyme activity.
    
  